Keywords
How to Cite
Abstract
This article examines the legal nature of license agreements in the field of biotechnology through a comparison of the main legal systems. The study considers the theoretical foundations of patent licensing and analyzes the question of whether licenses are purely contractual instruments or possess characteristics close to property rights. By examining the legal systems of the United States, the European Union, Japan, China, South Korea, Russia, and Uzbekistan, the study identifies the key differences in understanding license agreements. The article demonstrates that the unique characteristics of biotechnology — in particular, long development periods, significant capital requirements, and complex regulatory systems — necessitate a special legal approach. The study proposes a mixed approach for Uzbekistan that balances contractual flexibility and property protection. Specific recommendations are provided on adapting national legislation to international best practices and meeting the needs specific to biotechnology.
References
Abbott Laboratories v. Diamedix Corp., 47 F.3d 1128 (Fed. Cir. 1995).
Arora, A., Fosfuri, A., & Gambardella, A. (2001). Markets for technology: The economics of innovation and corporate strategy. MIT Press.
Bayh-Dole qonuni, 35 U.S.C. §§ 200-212 (1980).
Beier, F. K., & Straus, J. (2002). The patent system and its informational function yesterday and today. IIC Studies, 23, 3-36.
BIO (Biotechnology Innovation Organization). (2021). The value of biopharmaceutical innovation. https://www.bio.org
Blair, R. D., & Cotter, T. F. (2005). Intellectual property: Economic and legal dimensions of rights and remedies. Cambridge University Press.
Burk, D. L., & Lemley, M. A. (2009). The patent crisis and how the courts can solve it. University of Chicago Press.
Chisum, D. S. (2019). Chisum on patents (Vol. 6). Matthew Bender.
O‘zbekiston Respublikasi Fuqarolik kodeksi, 1036, 1089-moddalar (1996).
Rossiya Federatsiyasi Fuqarolik kodeksi, 1235-modda (2006).
Mualliflik huquqi qonuni, 17 U.S.C. § 101 va keyingilari (1976).
De Forest Radio Telephone Co. v. United States, 273 U.S. 236 (1927).
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20-33. https://doi.org/10.1016/j.jhealeco.2016.01.012
Yevropa Parlamenti va Kengashining 1998-yil 6-iyuldagi 98/44/EC direktivasi biotexnologik ixtirolarning huquqiy himoyasi to‘g‘risida. Rasmiy jurnal, L 213, 13-21.
Yevropa Parlamenti va Kengashining 2004-yil 29-apreldagi 2004/48/EC direktivasi intellektual mulk huquqlarini ijro etish to‘g‘risida. Rasmiy jurnal, L 157, 45-86.
Dittrich, R. (2000). Österreichisches und internationales Immaterialgüterrecht (2-nashr). Manz.
Dozortsev, V. A. (2005). Intellektualnye prava: Ponyatie. Sistema. Zadachi kodifikatsii [Intellektual huquqlar: Konsepsiya, tizim, kodifikatsiya vazifalari]. Statut.
Dworkin, R. (1986). Law's empire. Harvard University Press.
Eisenberg, R. S. (1989). Patents and the progress of science: Exclusive rights and experimental use. University of Chicago Law Review, 56(3), 1017-1086.
Eisenberg, R. S. (1996). Public research and private development: Patents and technology transfer in government-sponsored research. Virginia Law Review, 82(8), 1663-1727. https://doi.org/10.2307/1073686
Yevropa sudi. (1966). Consten and Grundig v. Commission, Qo‘shilgan ishlar 56 va 58/64.
Yevropa dori-darmonlar agentligi. (2019). Clinical trials regulation. https://www.ema.europa.eu
Godt, C. (2007). Technology transfer in the TRIPS age: The need for new global concepts and structures. Gower Publishing.
Hansmann, H., & Kraakman, R. (2002). Property, contract, and verification: The numerus clausus problem and the divisibility of rights. Journal of Legal Studies, 31(S2), S373-S420. https://doi.org/10.1086/342098
Hutchinson, T., & Duncan, N. (2012). Defining and describing what we do: Doctrinal legal research. Deakin Law Review, 17(1), 83-119.
Yaponiya Patent idorasi. (2020). Guidelines for patent examination: Biotechnology inventions. https://www.jpo.go.jp
Karimov, S. (2019). Intellectual property law in Uzbekistan: Current state and reform perspectives. Tashkent Law Review, 15(2), 45-67.
Kim, J., & Kim, S. (2016). Korean patent law and practice. Kluwer Law International.
Kohler, J. (1900). Handbuch des deutschen Patentrechts [Nemis patent huquqi bo‘yicha qo‘llanma]. Bensheimer.
Lanham qonuni, 15 U.S.C. § 1051 va keyingilari (1946).
O‘zbekiston Respublikasining Ixtirolar, foydali modellar va sanoat namunalari to‘g‘risidagi qonuni, 11-modda (2001).
Lemley, M. A. (2008). Rethinking patent law's presumption of validity. Stanford Law Review, 60(1), 45-72.
Lemley, M. A., & Shapiro, C. (2007). Patent holdup and royalty stacking. Texas Law Review, 85(7), 1991-2049.
Maggs, P. B., & Zhiltsov, A. N. (2013). Russian civil law. Statut.
Merges, R. P. (2011). Justifying intellectual property. Harvard University Press.
Merges, R. P., & Menell, P. S. (2020). Intellectual property in the new technological age (8-nashr). Wolters Kluwer.
Michaels, R. (2006). The functional method of comparative law. M. Reimann & R. Zimmermann (Tahrir.), The Oxford handbook of comparative law ichida (339-382-betlar). Oxford University Press.
Sog‘liqni saqlash vazirligi (Janubiy Koreya). (2019). K-Bio/Health strategy 2025. Hukumat nashri.
Milliy tibbiy mahsulotlar boshqarmasi (Xitoy). (2020). Drug registration regulations. http://www.nmpa.gov.cn
National Research Council. (2015). Industrialization of biology: A roadmap to accelerate the advanced manufacturing of chemicals. National Academies Press.
OECD. (2018). Meeting policy challenges for a sustainable bioeconomy. OECD Publishing. https://doi.org/10.1787/9789264292345-en
Oqyulov, O. (2018). Intellektual mulk huquqi: Nazariya va amaliyot. Adolat.
Yaponiya Patent qonuni, 1959-yil 121-sonli qonun, 2019-yilgacha tahrir etilgan.
Koreya Respublikasi Patent qonuni, 2020-yilda tahrir etilgan.
Patent qonuni, 35 U.S.C. § 1 va keyingilari (1952).
Xitoy Xalq Respublikasi Patent qonuni, 2020-yilda tahrir etilgan.
Farmatsevtika va tibbiy asboblar agentligi (Yaponiya). (2020). Guideline for clinical trials. https://www.pmda.go.jp
Pisano, G. P. (2006). Science business: The promise, the reality, and the future of biotech. Harvard Business Press.
Rai, A. K., & Eisenberg, R. S. (2003). Bayh-Dole reform and the progress of biomedicine. Law and Contemporary Problems, 66(1-2), 289-314.
Reichman, J. H., & Dreyfuss, R. C. (2007). Harmonization without consensus: Critical reflections on drafting a substantive patent law treaty. Duke Law Journal, 57(1), 85-130.
O‘zbekiston Respublikasi. (2020). 2020-2030-yillar uchun milliy biotexnologiya rivojlanish strategiyasi. Prezident farmoni № UP-6079.
Siems, M. (2014). Comparative law. Cambridge University Press.
Xitoy Xalq Respublikasi Davlat kengashi. (2015). Made in China 2025. Hukumat Oq kitobi.
Takenaka, T. (2013). Japanese patent law: History and comparison with the United States. Edward Elgar Publishing.
Yevropa Ittifoqi to‘g‘risidagi shartnoma, 101-102-moddalar (2007).
Tritton, G., Davis, R., Edenborough, M., & Graham, J. (2018). Intellectual property in Europe (5-nashr). Sweet & Maxwell.
AQSH Adliya vazirligi & Federal savdo komissiyasi. (2017). Antitrust guidelines for the licensing of intellectual property. https://www.ftc.gov
AQSH Oziq-ovqat va dori-darmon idorasi. (2018). Drug approval process. https://www.fda.gov
Walsh, J. P., Arora, A., & Cohen, W. M. (2003). Research tool patenting and licensing and biomedical innovation. W. M. Cohen & S. A. Merrill (Tahrir.), Patents in the knowledge-based economy ichida (285-340-betlar). National Academies Press.
Zweigert, K., & Kötz, H. (2020). An introduction to comparative law (3-nashr). Oxford University Press.